N4P.Lライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (29 4月 2024 @ 22:45):

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom...

Stats
本日の出来高	644 688
平均出来高	759 144
時価総額	2.15M
EPS	£0 ( 2024-04-03 )
Last Dividend	£18.00 ( 1997-05-19 )
Next Dividend	£0 ( N/A )
P/E	-0.800
ATR14	£0.0340 (4.49%)

N4 Pharma PLC 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

N4 Pharma PLC 財務諸表

Annual	2023
収益:	£1 953.00
総利益:	£1 953.00 (100.00 %)
EPS:	£-0.00520

FY	2023
収益:	£1 953.00
総利益:	£1 953.00 (100.00 %)
EPS:	£-0.00520

FY	2022
収益:	£0
総利益:	£0 (0.00 %)
EPS:	£-0.00550

FY	2021
収益:	£0.00
総利益:	£0.00 (0.00 %)
EPS:	£-0.00850

Financial Reports:

No articles found.

N4 Pharma PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

N4 Pharma PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	£16.00	1995-05-22
Last Dividend	£18.00	1997-05-19
Next Dividend	£0	N/A
Payout Date	1997-07-01
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	£85.20	--
Avg. Dividend % Per Year	0.00%	--
Score	1.05	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-10-21)

£0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.05

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
1995	£0	0.00%
1996	£0	0.00%
1997	£0	0.00%
1998	£0	0.00%
1999	£0	0.00%
2000	£0	0.00%
2001	£0	0.00%
2002	£0	0.00%
2003	£0	0.00%
2004	£0	0.00%
2005	£0	0.00%
2006	£0	0.00%
2007	£0	0.00%
2008	£0	0.00%
2009	£0	0.00%
2010	£0	0.00%
2011	£0	0.00%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£0	0.00%
2020	£0	0.00%
2021	£0	0.00%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
WTB.L	Dividend Knight	2023-05-25	Annually	33	0.87%
NTV.L	Dividend Knight	2023-07-20	Semi-Annually	25	4.03%
EMG.L	Dividend King	2023-08-10	Semi-Annually	31	3.60%
SPT.L	Dividend Knight	2023-08-10	Semi-Annually	32	1.51%
JD.L	Dividend Knight	2023-12-07	Annually	28	0.21%
BUT.L	Dividend King	2023-08-03	Quarterly	49	1.28%
PNL.L	Dividend Knight	2023-08-24	Quarterly	41	0.75%
FSFL.L	Dividend Knight	2023-07-20	Quarterly	11	3.85%
AERI.L	Dividend Junior	2023-08-17	Quarterly	6	2.80%
THRG.L	Dividend Knight	2023-08-03	Semi-Annually	52	1.02%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-649.94	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.995	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.987	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	14.86	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	14.73	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	12.57	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.00478	2.00	-0.00159	-0.00318	[0 - 30]
freeCashFlowPerShareTTM	-0.00478	2.00	-0.00239	-0.00478	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-729.44	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.00153	0.800	-3.32	-2.66	[0.5 - 2]
Total Score				-1.289

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.545	1.000	-0.257	0	[1 - 100]
returnOnEquityTTM	-0.987	2.50	-7.76	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.00478	2.00	-0.00159	-0.00478	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.00478	2.00	-0.00159	-0.00318	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.883	1.500	-9.22	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-619.10	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-3.03

N4 Pharma PLC

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.